White House Refuses to Say Whether Ukraine Will Receive Toxic Depleted Uranium Ammo
A Biden official wouldn’t disclose whether Bradley Fighting Vehicles will be equipped with the anti-tank rounds, linked to cancer and birth defects.
World
The Coronavirus Crisis
NIH Urged to Consider Banning Wuhan Institute of Virology From Future Grants
The Wuhan lab has continued to stonewall NIH and EcoHealth Alliance on scientific documentation, an inspector general report confirmed.
Apple Brings Mainland Chinese Web Censorship to Hong Kong
Apple quietly expanded the use of Chinese company Tencent’s website blacklist to users in Hong Kong — and no one will answer questions about it.
Elon Musk Caves to Pressure From India to Remove BBC Doc Critical of Modi
Officials from India's ruling right-wing party said American tech companies like Twitter and YouTube complied with demands to remove the documentary.
Turkey’s Next Elections Could Be the Country’s Last Real Democratic Vote
In an apparent bid to stamp out the opposition — perhaps forever — Recep Tayyip Erdogan called elections a month early.
Did Mexico's Top Cop Play a Role in the Killing of a DEA Informant?
A man expected to testify in Genaro García Luna's federal trial has accused the ex-security chief of helping to reveal the informant's identity to a cartel.
U.S. Military Vets in Ukraine Are Fighting Each Other in Court
Amid accusations of fraud and sexual misconduct, the founders of the high-profile Mozart Group are waging a personal war back home.
Voices
Empire by Invitation
African leaders are asking for more U.S. counterterrorism support. They should be careful what they wish for.
Mexico’s Former Top Cop Is on Trial in New York. Will the U.S. Be Implicated?
Genaro García Luna, a drug war insider facing charges of colluding with two major cartels, was in a position to collect dirt on officials on both sides of the border.
The Coronavirus Crisis
Covid-19 Drugmakers Pressured Twitter to Censor Activists Pushing for Generic Vaccine
The social media pressure campaign was just a part of the pharmaceutical industry's successful lobbying blitz to retain patents — and make record profits.